| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Classified under Health Care Equipment & Supplies (Health Care sector), NVCR's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 461.4K | $5.14M | - | |
| CEO | 422.6K | $5.62M | - | |
| Dir | 416.7K | $4.65M | - | |
| Other | 328.4K | - | - | |
| Other | 267.2K | $3.56M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 2, 2025 | Leonard Frank X76 | EVP, President, Novocure Oncology | Sell10b5-1 | 30,196 | $17.50 | $528,412.59 | -15.2% | -28.5% | -7.2% | |
| May 3, 2025 | Paravasthu Mukund69 | Chief Operating Officer | Sell | 592 | $17.91 | $10,604.20 | -0.7% | -37.6% | - | |
| Mar 3, 2025 | Cordova Ashley75 | Chief Executive Officer | Sell | 2,053 | $18.54 | $38,055.02 | -1.0% | -7.4% | -27.8% | |
| Mar 3, 2025 | Leonard Frank X76 | EVP, President, Novocure Oncology | Sell | 2,527 | $18.54 | $46,841.23 | -1.7% | -7.4% | -27.8% | |
| Mar 3, 2025 | Paravasthu Mukund69 | Chief Operating Officer | Sell | 250 | $18.54 | $4,634.08 | -0.8% | -7.4% | -27.8% | |
| Mar 3, 2025 | Weinberg Uri72 | Chief Innovation Officer | Sell | 268 | $18.92 | $5,071.02 | -0.2% | -7.4% | -27.8% | |
| Feb 28, 2025 | Weinberg Uri72 | Chief Innovation Officer | Sell | 4,637 | $18.75 | $86,949.24 | -2.7% | +1.7% | -28.4% | |
| Feb 28, 2025 | Cordova Ashley75 | Chief Executive Officer | Sell | 13,494 | $19.72 | $266,126.29 | -6.1% | +1.7% | -28.4% | |
| Feb 28, 2025 | Paravasthu Mukund69 | Chief Operating Officer | Sell | 2,014 | $19.71 | $39,687.51 | -6.4% | +1.7% | -28.4% | |
| Feb 28, 2025 | Leonard Frank X76 | EVP, President, Novocure Oncology | Sell | 15,036 | $19.70 | $296,256.84 | -9.3% | +1.7% | -28.4% |